September 4th, 2014
The Belgian jury has awarded trastuzumab emtansine, KADCYLA T-DM1 (ROCHE)
For additional information, please contact: Mr. Baudouin van de WERVE,
baudouin.van.de.werve@actuamedica.be
September 4th, 2014
The Belgian jury has awarded trastuzumab emtansine, KADCYLA T-DM1 (ROCHE)
For additional information, please contact: Mr. Baudouin van de WERVE,
baudouin.van.de.werve@actuamedica.be